[1]雷彦平,李彩娟,彭慧霞.病灶剔除术联合复方醋酸棉酚和曼月乐治疗子宫腺肌症疗效及可行性研究[J].陕西医学杂志,2021,50(5):579-582.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.016]
　LEI Yanping,LI Caijuan,PENG Huixia.Efficacy and feasibility of lesion removal combined with compound gossypol acetate and Mirena in treatment of adenomyosis[J].,2021,50(5):579-582.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.016]
点击复制

病灶剔除术联合复方醋酸棉酚和曼月乐治疗子宫腺肌症疗效及可行性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年5期
页码:
579-582
栏目:
临床研究
出版日期:
2021-05-05

文章信息/Info

Title:
Efficacy and feasibility of lesion removal combined with compound gossypol acetate and Mirena in treatment of adenomyosis
作者:
雷彦平1; 李彩娟1; 彭慧霞2
(1.渭南市妇幼保健院,陕西 渭南 714000; 2.西安交通大学第二附属医院,陕西 西安710004)
Author(s):
LEI Yanping; LI Caijuan; PENG Huixia
(Weinan Maternal and Child Health Hospital,Weinan 714000,China)
关键词:
子宫腺肌症;  病灶剔除术;  复方醋酸棉酚片;  曼月乐;  子宫体积;  血红蛋白;  病灶面积
Keywords:
Adenomyosis;  Lesion removal;  Compound gossypol acetate tablets;  Mirena;  Uterine volume;  Hemoglobin;  Lesion area
分类号:
R 711.7
DOI:
DOI:10.3969/j.issn.1000-7377.2021.05.016
文献标志码:
A
摘要:
目的:探讨子宫腺肌症病灶剔除术后联合复方醋酸棉酚片和曼月乐治疗的疗效及可行性。方法:选择子宫腺肌症患者72例作为研究对象,随机分为手术组与联合组各36例。手术组给予病灶剔除术治疗,联合组在手术组治疗的基础上在术后给予复方醋酸棉酚片联合曼月乐治疗,记录两组预后效果。结果:两组术后1个月、术后3个月的子宫腺肌症病灶面积、子宫体积、疼痛评分低于术前(均P<0.05),联合组低于手术组(均P<0.05); 两组术后1个月、术后3个月的血红蛋白高于术前(均P<0.05),联合组高于手术组(P<0.05); 两组术后6个月复发率对比,联合组低于手术组(P<0.05)。结论:子宫腺肌症病灶剔除术后联合复方醋酸棉酚片和曼月乐治疗能减少病灶面积、子宫体积,缓解痛经程度,促进患者血红蛋白的恢复,降低复发率。
Abstract:
Objective:To investigate the efficacy and feasibility of combined treatment with compound gossypol acetate tablets and Mirena after adenomyosis lesion removal.Methods:72 cases of patients with adenomyosis were selected and divided into operation group and combined group,with 36 cases in each groups.The operation group was treated with lesion removal,and the combined group was treated with compound gossypol acetate tablets combined with Mirena on the basis of the operation group.The prognostic effects of the two groups were recorded.Results:The adenomyosis lesion area,uterine volume,and pain scores of the two groups at 1 month and 3 months after operation were lower than those before operation,and the combined group was lower than the operation group(all P<0.05).The hemoglobin of the two groups at 1 month and 3 months after operation were higher than that before operation,and the combined group were higher than the operation group(all P<0.05).The recurrence rate of the combined group 6 months after operation was lower than that of the operation group(P<0.05).Conclusion:Combined treatment with compound gossypol acetate and Mirena after adenomyosis lesion removal can promote the reduction of lesion area and uterine volume,relieve the degree of dysmenorrhea,and promote the recovery of hemoglobin,and reduce the recurrence rate.

参考文献/References:

[1] 刘 芳,巨 瑛,杨红睚,等.桂枝茯苓丸联合西药治疗子宫腺肌病继发性痛经患者的临床疗效及对血清IL-6、PGE2及ET的影响[J].陕西中医,2016,37(10):1279-1280.
[2] 郝世辉,顾雅楠,黄晓虹.高强度聚焦超声联合动脉栓塞与腹腔镜肌瘤挖除术治疗青年女性子宫腺肌瘤疗效对比研究[J].陕西医学杂志,2019,48(11):1443-1446.
[3] 田 艺,张 坤,苏 青,等.腹腔镜下子宫肌瘤微创剔除术治疗子宫肌瘤临床疗效及对患者应激反应的影响研究[J].陕西医学杂志,2018,47(1):93-95.
[4] Benetti-Pinto CL,Mira TAA,Yela DA,et al.Pharmacological treatment for symptomatic adenomyosis:A systematic review[J].Revista Brasilra De Ginecologiae Obstetrícia,2019,41(9):564-574.
[5] 冯九香,李婉萍.腹腔镜下子宫肌瘤剔除术对患者预后及血清疼痛指标的影响[J].医学临床研究,2018,35(1):108-110.
[6] 蒋珊珊,胡京辉,沈 燕.腹腔镜下子宫肌瘤剔除术联合术前应用促性腺激素释放激素激动剂治疗大子宫肌瘤的疗效观察[J].中国内镜杂志,2017,23(5):1-4.
[7] Guo Q,Xu F,Ding Z,et al.High intensity focused ultrasound treatment of adenomyosis:A comparative study[J].Int J Hyperthermia,2018,35(1):505-509.
[8] Haiyan S,Lin W,Shuhua H,et al.High-intensity focused ultrasound(HIFU)combined with gonadotropin-releasing hormone analogs(GnRHa)and levonorgestrel-releasing intrauterine system(LNG-IUS)for adenomyosis:A case series with long-term follow up[J].Int J Hyperthermia,2019,36(1):1179-1185.
[9] Huang L,Ji X,Wang X,et al.Adjuvant therapy of Chinese herbal medicine for the treatment of adenomyosis:A protocol for systematic review[J].Medicine(Baltimore),2020,99(25):20560.
[10] Li L,Leng J,Jia S,et al.Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system[J].Int J Gynaecol Obstet,2019,146(3):357-363.
[11] Li Q,Ding Y,Zhang XY,et al.Drug therapy for adenomyosis:a prospective,nonrandomized,parallel-controlled study[J].J Int Med Res,2018,46(5):1855-1865.
[12] Li Q,Yuan M,Li N,et al.The efficacy of medical treatment for adenomyosis after adenomyomectomy[J].J Obstet Gynaecol Res,2020,46(10):2092-2099.
[13] 王 贺,杨 清.子宫腺肌症病灶剔除术后联合促性腺激素释放激素激动剂治疗的疗效及妊娠结局[J].中国医科大学学报,2015,44(1):81-83.
[14] 郭春凤,黄修菊,张琴悦,等.腹腔镜病灶剔除术联合孕三烯酮治疗子宫腺肌病疗效分析[J].中国妇幼保健,2018,33(18):4297-4299.
[15] Song SY,Lee SY,Kim HY,et al.Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis[J].Medicine(Baltimore),2020,99(22):20421.
[16] Vannuccini S,Luisi S,Tosti C,et al.Role of medical therapy in the management of uterine adenomyosis[J].Fertil Steril,2018,109(3):398-405.
[17] 张 丽,董冰莹,袁小丽.术前应用GnRH-a对子宫肌瘤腹腔镜剔除术患者手术效果的影响[J].医学临床研究,2020,37(6):950-952.
[18] 陈葵喜,马 俊,颜为红.促性腺激素释放素激动剂预防子宫腺肌症病灶剔除术后复发及疗效的研究[J].医学综述,2017,23(12):2470-2473.
[19] Gao Y,Shan S,Zhao X,et al.Clinical efficacy of adenomyomectomy using “H” type incision combined with Mirena in the treatment of adenomyosis[J].Medicine(Baltimore),2019,98(11):14579.
[20] Grandi G,Farulla A,Sileo FG,et al.Levonorgestrel-releasing intra-uterine systems as female contraceptives[J].Expert Opin Pharmacother,2018,19(7):677-686.
[21] Li Y,Qi H,Ma W,et al.Temporarily blocking the uterine artery to dig out a diffused adenomyosis lesion treated laparoscopically[J].J Minim Invasive Gynecol,2017,24(3):349-352.

相似文献/References:

[1]芦 霄,秦海英,张 悦,等.超声引导下微创消融治疗子宫腺肌症疗效评估[J].陕西医学杂志,2021,50(1):32.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.008]
　LU Xiao,QIN Haiying,ZHANG Yue,et al.Evaluation of ultrasound-guided minimally invasive ablation of adenomyosis[J].,2021,50(5):32.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.008]

备注/Memo

备注/Memo:
基金项目:陕西省科学技术研究发展计划项目(2011K12-03-13)
更新日期/Last Update: 2021-05-06